Fierce Pharma

NOVEMBER 15, 2024

In a flurry of activity, Europe’s human medicines committee has done an about-face on Eisai and Biogen’s Alzheimer’s disease med Leqembi, endorsed a clutch of biosimilars, recommended a slew of lab | In a flurry of activity, the European Medicines Agency's CHMP has done an about-face on Eisai and Biogen’s Alzheimer’s disease med Leqembi, endorsed a clutch of biosimilars, recommended a slew of label expansions and put forward new cancer and COVID drugs for approval.

Medicine 224

Medicine 224

MedCity News

NOVEMBER 15, 2024

The best healthcare technology emerges from collaborative efforts. Here’s why working alongside physicians, nurses, and home health caregivers builds a stronger foundation. The post Centering Caregiver and Provider Feedback in Home-Based Care Innovation appeared first on MedCity News.

Physicians 102

Physicians Healthcare Healthcare 102

Fierce Pharma

NOVEMBER 15, 2024

With multiple drugmakers already announcing a slew of radiopharmaceutical moves this year, France’s Orano Med is doubling down on the nuclear medicine craze. | Orano Med—developing targeted alpha therapies for cancer—kicked off construction of a 250 million euro plant in the Bessines-sur-Gartempe commune of France. Dubbed the Advanced Thorium Extraction Facility, the new 7,000-square-meter site is slated to manufacture thorium-228, a precursor of lead-212, for radioligand therapies.

Manufacturing 182

Manufacturing Medicine Leads 182

MedCity News

NOVEMBER 15, 2024

Providing proactive and preventive health-focused living among younger, less affluent senior populations — and extending this into value-based care — just makes sense. The post Bundling Boomer Housing with On-site Primary Care and Wellness-Focused Living: It Just Makes Sense appeared first on MedCity News.

Patients 100

Patients Healthcare Healthcare 100

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Fierce Pharma

NOVEMBER 15, 2024

Azurity Pharmaceuticals has earned an FDA approval for Danziten, a new formulation of Novartis’ chronic myeloid leukemia (CML) blockbuster Tasigna.

FDA 185

FDA Patients Pharmaceutical 185

MedCity News

NOVEMBER 15, 2024

To overcome challenges and ensure that RPM reaches its full potential, both providers and payers need to implement several key strategies — and technology is a key component to making everything easier on all organizations. The post Remote Patient Monitoring Works … What are Payers and Providers Waiting for? appeared first on MedCity News.

Patients 98

Patients 98

MedCity News

NOVEMBER 15, 2024

Halozyme’s offer comes as Evotec deals with several business setbacks and a languishing stock price. Earlier this year, Evotec implemented a cost-saving corporate restructuring. The post Halozyme Makes Unsolicited €2B Takeover Bid for Drug R&D Services Firm Evotec appeared first on MedCity News.

87

87

eMediWrite

NOVEMBER 15, 2024

In the highly competitive pharmaceutical industry, your brand’s visibility plays a crucial role, i.e., it can make or break your market success. If your brand is struggling to make a lasting impression, several factors may be contributing to its diminishing presence. The good news? With the right strategies, you can boost your visibility and regain your competitive edge.

Pharma 52

Pharma Media Competition Education 52

MedCity News

NOVEMBER 15, 2024

To ramp up its food-as-medicine support, NationsBenefits has acquired Good Measures, a company that offers coaching and personalized food prescriptions. The post NationsBenefits Acquires Good Measures to Advance Food-as-Medicine Offerings appeared first on MedCity News.

Food 81

Food Medicine Prescription 81

Pharma Marketing Network

NOVEMBER 15, 2024

In the world of pharmaceutical marketing, social media marketing strategies are more than a trend; they’re a necessity. But with strict regulations and evolving consumer expectations, how do pharma brands navigate the digital landscape effectively? The answer lies in a mix of proven strategies designed for this unique sector. Table of Contents Sr# Headings 1 Know Your Audience and Their Needs 2 Leverage Branded and Unbranded Content 3 Engage Responsibly and Transparently 4 Utilize Influenc

Media 52

Media Pharma Marketing Medical 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmExec

NOVEMBER 15, 2024

A look at one biotech’s mission to map the immune system using artificial intelligence—and how its growth as a Big Pharma partner could help unlock the potential of next-generation cancer treatments.

Pharma 52

Pharma 52

Pharma Marketing Network

NOVEMBER 15, 2024

In today’s digital-first world, Pay Per Click (PPC) advertising has become an essential strategy for pharma marketing executives. Imagine having a tool that allows you to target specific audiences actively searching for healthcare solutions, like branded medications or treatment options. PPC does just that. But how does it work, and how can you make the most of it in the competitive pharmaceutical industry?

Marketing 52

Marketing Pharma Side effects Medical 52

PharmExec

NOVEMBER 15, 2024

Developments in the world of artificial intelligence continue to accelerate at a rapid pace. Our November issue of Pharmaceutical Executive explores a few of those that are starting to deliver measurable gains for the industry.

Pharmaceutical 52

Pharmaceutical 52

Pharma Marketing Network

NOVEMBER 15, 2024

The digital landscape has transformed how pharmaceutical brands reach healthcare professionals (HCPs) and patients. Digital advertising is no longer just a nice addition; it’s a must-have for every successful pharma marketing strategy. But how do you make your campaigns stand out in such a highly regulated and competitive industry? Let’s explore some proven strategies that will help you master digital advertising and drive significant results.

Pharma 52

Pharma Media Engineering Marketing 52

Advertisement

European Pharmaceutical Review

NOVEMBER 15, 2024

BeiGene Ltd is planning to change its company’s name to BeOne Medicines Ltd. The oncology organisation stated that its new name and logo illustrates its “focus on coming together against cancer”. BeiGene – a new vision “Be” represents being disease free, with “One” underlining [BeiGene’s] shared mission to overcome [cancer]” Within the new logo design, “Be” represents being disease free, with “One” underlining the company’s shared mission to overcome the disease, according to B

Medicine 52

Medicine Engineering Manufacturing Medical 52

Pharmaceutical Technology

NOVEMBER 15, 2024

The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only nilotinib formulation that does not require mealtime restrictions, to treat chronic myeloid leukaemia (CML).

Food and Drug Administration 52

Food and Drug Administration Pharmaceutical FDA Food 52

Scott Burrows

NOVEMBER 15, 2024

In the ever-changing, high-pressure world of healthcare, the ability to navigate crisis and uncertainty is more critical than ever. Whether it’s managing an influx of patients, adapting to new healthcare protocols, or overcoming staffing shortages, healthcare professionals face challenges that demand more than just skill — they require vision. When faced with adversity, a clear and compelling vision can serve as the anchor that keeps healthcare teams grounded and moving forward.

Healthcare 52

Healthcare Healthcare Patients Management 52

Pharmaceutical Commerce

NOVEMBER 15, 2024

In the first part of this roundtable discussion, a panel of subject matter experts introduce themselves, while discussing why the pharma supply chain sees value in this technology and why its use has fluctuated over the past decade.

Pharmaceutical 52

Pharmaceutical Pharma 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales

Zymewire

NOVEMBER 15, 2024

In the fast-paced world of life sciences, effective prospecting is essential for driving growth and staying ahead of the competition—especially as teams prepare strategies and plans for the year ahead. But if your team is using a legacy database—an outdated, inefficient tool that wasn’t built for today’s needs—you're likely missing out on opportunities without even knowing it.

Sales 52

Sales Prospecting Competition 52

Pharmaceutical Technology

NOVEMBER 15, 2024

MSD has secured an exclusive worldwide license from LaNova Medicines for developing, manufacturing, and commercialising the latter’s new investigational programmed cell death 1 (PD-1)/vascular endothelial growth factor (VEGF) bispecific antibody, LM-299.

Manufacturing 52

Manufacturing Medicine 52

PharmaTech

NOVEMBER 15, 2024

Executives at Avantor talk about the future of the biopharmaceutical industry and the anticipated impact that a wave of next-generation biotherapeutics will bring.

52

52

Pharmaceutical Commerce

NOVEMBER 15, 2024

The collaboration ultimately benefits oncology patients, as life science companies will be able to access their cancer journey data more efficiently.

Patients 52

Patients 52

Advertisement

Distribution

PharmaTech

NOVEMBER 15, 2024

Avantor's newly launched expanded Innovation Center in Bridgewater, NJ, is designed for integrated workflows and features purpose-built collaboration spaces.

52

52

PharmExec

NOVEMBER 15, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharmaceutical 52

Pharmaceutical 52

Pharmaceutical Technology

NOVEMBER 15, 2024

AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease vaccine like therapy.

52

52

PharmExec

NOVEMBER 15, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Patients 52

Patients FDA 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Pharmaceutical Technology

NOVEMBER 15, 2024

The two-day Oncology event will see industry experts from across the clinical trial space holding talks on subjects from AI to business

Patients 52

Patients 52

PharmExec

NOVEMBER 15, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmaceutical Technology

NOVEMBER 15, 2024

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

FDA 52

FDA 52

PharmExec

NOVEMBER 15, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

FDA 52

FDA 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution